In a recent publication, Marty and co-workers reported their finding, that HLA class I genotype of cancer subjects shape their tumors’ mutational profile by eliminating through immunological reactions those neoepitopes that are highly presented by the HLAs [156]. Here, HLA-S is linked to cancer.